We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$3.51B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+4.6%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$726M
AUM Growth
+$35.7M
(+5.2%)
Cap. Flow
+$4.67M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
84.91%
Holding
84
New
3
Increased
11
Reduced
51
Closed
6
Top Buys
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.63M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$1.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.19M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$980K |
Sector Composition
| 1 | Financials | 7.16% |
| 2 | Industrials | 0.48% |
| 3 | Technology | 0.26% |
| 4 | Consumer Staples | 0.16% |
| 5 | Healthcare | 0.12% |
Similar funds
BCP
ACA
IIM
TH
TYCC
TCM
DILIC
KCM
Aspiriant LLC's Q2 2014 Portfolio in Review
As of Q2 2014, Aspiriant LLC held 84 positions worth $726M, up 5.2% from $690M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Aspiriant LLC's Q2 2014 filing shows 3 new, 11 increased, 51 reduced and 6 closed positions. Its largest new stake was Wendy's: 64,196 shares worth $548K. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $1.63M.
By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Industrials and Technology.
- Aspiriant LLC's largest Q2 2014 buy was Wendy's: 64,196 shares worth $548K.
- Aspiriant LLC added most to iShares Core S&P US Value ETF in Q2 2014, an estimated $8.16M increase.
- Aspiriant LLC's biggest Q2 2014 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $1.63M.
- Aspiriant LLC fully exited Mandiant, Inc. Common Stock in Q2 2014, selling an estimated $682K.
- Aspiriant LLC's ten largest holdings make up 85% of its $726M portfolio in Q2 2014.
- Aspiriant LLC opened 3 new positions and closed 6 in Q2 2014.
- Aspiriant LLC's portfolio value rose 5.2% quarter-over-quarter to $726M.
Based on Aspiriant LLC's 13F filing for Q2 2014, filed 12 Aug 2014.